|
MechanismTubulin inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1995 |
100 Clinical Results associated with ACARPIA Farmaceutici S.r.l.
0 Patents (Medical) associated with ACARPIA Farmaceutici S.r.l.
100 Deals associated with ACARPIA Farmaceutici S.r.l.
100 Translational Medicine associated with ACARPIA Farmaceutici S.r.l.